PPBT
Purple Biotech
PPBT
PPBT
19 hedge funds and large institutions have $513K invested in Purple Biotech in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
6.93% more ownership
Funds ownership: 1.47% → 8.4% (+6.9%)
73% less call options, than puts
Call options by funds: $9K | Put options by funds: $33K
Holders
19
Holding in Top 10
–
Calls
$9K
Puts
$33K
Top Buyers
| 1 | +$341K | |
| 2 | +$113K | |
| 3 | +$10.7K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$7.11K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$6.58K |
Top Sellers
| 1 | -$28K | |
| 2 | -$7.12K | |
| 3 | -$3.61K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.07K |
| 5 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
-$65 |
